Grant: CIHR Café Scientifique Program

Chronic non-cancer pain (CNCP) affects approximately 25% of Canadians. Opioids such as codeine (e.g. Tylenol 3), oxycodone (e.g. OxyContin) and morphine are medications that are frequently prescribed for the management of patients with chronic pain. While these medications have an important role in managing chronic pain, there are concerns about them being misused, causing addiction, or being diverted for sale on the street for non-medical use. On the other hand CNCP continues to be inadequately treated. Because of these concerns, a new national guideline has been developed which was released in April 2010. This guideline provides recommendations to help health care professionals use opioids safely and effectively in treatment of CNCP. In addition to informing caregivers, part of the essential process of care is informed patients and the public. The National Faculty Working Groups include a working group on Knowledge Translation to Patients and the Public. This group focuses on creation and dissemination of material to support patient and public education. The Cafe Scientifique proposal will support the goals of patient and public education.